Direct medical costs of monitoring and treating patients with Takayasu arteritis in Italy

European Journal of Health Economics

Volumn 5, Issue 4, 2004, Pages 330-334

  Krulichova, Iva ^a   Gamba, Sara ^b   Ricci, Elena ^a   Garattini, Livio ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Clin Res Ctr Rare Dis Aldo C   (Italy)

Author keywords

Cost; Italy; Rare disease; Resource consumption; Takayasu arteritis

Indexed keywords

CORTICOSTEROID; CYTOTOXIC AGENT;

ADOLESCENT; ADULT; AGED; AORTA ARCH SYNDROME; CLINICAL ARTICLE; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; ITALY; LABORATORY TEST; MALE; NATIONAL HEALTH SERVICE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; ARTICLE; CLINICAL TRIAL; COST; ECONOMICS; MIDDLE AGED; MULTICENTER STUDY;

ADOLESCENT; ADULT; AGED; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; ITALY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TAKAYASU'S ARTERITIS;

EID: 17444409963     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-004-0248-z     Document Type: Review

References (15)

1. Neidhart B, Kosek R, Machmann LM, Stey C (2001) Exertional dyspnea as initial manifestation of Takayasu's arteritis - a case report and literature review. BMC Pulm Med 1:3
2. Kerr G (1994) Takayasu's arteritis. Curr Opin Rheumatol 6:32-38
3. Vanoli M, Miani S, Amft N, Bacchiani L, Radelli L, Scorza R (1995) Takayasu's arteritis in Italian patients. Clin Exp Rheumatol 13:45-50
4. Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 33:1129-1134
5. Cotch MF (2000) The socioeconomic impact of vasculitis. Curr Opin Rheumatol 12:20-23
6. Parra JR, Perler BA (2003) Takayasu's disease. Semin Vasc Surg 16:200-208
7. Vanoli M, Bacchiani G, Origini L, Scorza R (2001) Takayasu's arteritis: a changing disease. J Nephrol 14:497-505
8. Sato EI, Hatta FS, Levy-Neto M, Fernandes S (1998) Demographic, clinical, and angiographic data of patients with Takayasu arteritis in Brazil. Int J Cardiol 66 [Suppl 1]:67-70
9. Garattini L, Tediosi F, Ghislandi S, Orzella L, Rossi C (2000) How do Italian pharmacoeconomists evaluate indirect costs. Value Health 3:270-276
10. Taroni F (1996) DRG/ROD e nuovo sistema di finanziamento degli ospedali. Pensiero Scientifico: Rome
11. Salvarani C, Daina E, Vanoli M, Rossi C, Sabbadini MG, Bertollini G (2002) Takayasu arteritis: a study of 104 Italian patients. Arthritis Rheum 46 [Suppl]:184
12. Garattini L, Castelnuovo E, Lanzeni D, Viscarra C (2003) Durata e costo delle visite in medicina generale: il progetto DYSCO. Farmacoeconomia e Percorsi Terapeutici 4:109-114
13. Anonymous (1997) Italian directory of medicines and manufacturers. OEMF: Milan
14. Barber JA, Thompson SG (2000) Analysis of cost data in randomized trials: an application of the non-parametric bootstrap. Stat Med 19:3219-3236
15. Hunder G (1996) Vasculitis: diagnosis and therapy. Am J Med 100 [Suppl 2A]:37S-45S